Abstract:Background As a poorly water-soluble drug, the oral application of morin is limited by its low oral bioavailability. In this study, a new self-nanoemulsifying drug delivery system (SNEDDS), based on the phospholipid complex technique, was developed to improve the oral bioavailability of morin. Methods Morin-phospholipid complex (MPC) was prepared by a solvent evaporation method and characterized by infrared spectroscopy and X-ray diffraction. After formation of MPC, it was found that the liposolubility of morin was significantly increased, as verified through solubility studies. An orthogonal design was employed to screen the blank SNEDDS, using emulsifying rate and particle size as evaluation indices. Ternary phase diagrams were then constructed to investigate the effects of drug loading on the self-emulsifying performance of the optimized blank SNEDDS. Subsequently, in vivo pharmacokinetic parameters of the morin-phospholipid complex self-nanoemulsifying drug delivery system (MPC-SNEDDS) were investigated in Wistar rats (200 mg/kg of morin by oral administration). Results The optimum formulation was composed of Labrafil® M 1944 CS, Cremophor® RH 40, and Transcutol® P (3:5:3, w/w), which gave a mean particle size of approximately 140 nm. Oral delivery of the MPC-SNEDDS exhibited a significantly greater Cmax (28.60 μg/mL) than the morin suspension (5.53 μg/mL) or MPC suspension (23.74 μg/mL) (all P < 0.05). Tmax was prolonged from 0.48 to 0.77 hours and to 1 hour for MPC and MPC-SNEDDS, respectively. In addition, the relative oral bioavailability of morin formulated in the MPC-SNEDDS was 6.23-fold higher than that of the morin suspension, and was significantly higher than that of the MPC suspension (P < 0.05). Conclusion The study demonstrated that a SNEDDS combined with the phospholipid complex technique was a promising strategy to enhance the oral bioavailability of morin.

Development of Monolithic Osmotic Pump Tablet System for Isosorbide-5-Mononitrate Delivery and Evaluation of It in Vitro and in Vivo

In Vitro and in Vivo Evaluation of Novel Osmotic Pump Tablets of Isosorbide-5-mononitrate Containing Polyvinyl Pyrrolidone (PVP) for Controlled Release.

Study on Preparation of Isosorbide-5-mononitrate Osmotic Pump Tablets and Its Release Mechanism in Vitro

Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate.

Studies on sustained-release tablet of isosorbide-5-mononitrate

Development and Evaluation of High Bioavailable Sustained-Release Nimodipine Tablets Prepared with Monolithic Osmotic Pump Technology

A Novel Subcutaneous Infusion Delivery System Based on Osmotic Pump:In Vitroandin Vivoevaluation

Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation

[Studies on Preparation of Isosorbide-5-mononitrate Pulsatile Controlled-Release Pellets and Various Influence Factors].

A Water-Insoluble Drug Monolithic Osmotic Tablet System Utilizing Gum Arabic As an Osmotic, Suspending and Expanding Agent

Preparation of isosorbide-5-mononitrate pellets by extrusion/spheronization and study on its properties

A Novel Multi-Unit Tablet for Treating Circadian Rhythm Diseases

Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol

Effects of intermolecular interactions and solvent properties on the solid-liquid phase equilibrium of isosorbide 5-mononitrate

Preparation of monolithic osmotic pump system by coating the indented core tablet.

Solubility-modulated monolithic osmotic pump tablet for atenolol delivery.

Development and In vitro and In vivo Evaluations of a Microemulsion Formulation for the Oral Delivery of Oxaprozin

Design and Evaluation of Osmotic Pump-Based Controlled Release System of Ambroxol Hydrochloride.

Optimization of isosorbide mononitrate microporosity osmotic pump tablets formulation using response surface methodology

Preparation, Characterization, and in Vivo Evaluation of a Self-Nanoemulsifying Drug Delivery System (SNEDDS) Loaded with Morin-Phospholipid Complex

Formulation Study and Evaluation of Matrix and Three-layer Tablet Sustained Drug Delivery Systems Based on Carbopols with Isosorbite Mononitrate